Skip to main content
. 2017 Nov 8;5(11):E1144–E1150. doi: 10.1055/s-0043-119753

Table 4. Correlation between clinical outcomes, type of IPMN and dilation of the main duct. Mean follow-up of responders and not responders after PS.

Responders 1 Not responders P value 2
n (%) 14 (88 %)  2 (12 %)
Type of IPMN

  • BD-IPMN

  8 (57 %)  1 (50 %) 1

  • MD-IPMN

  6 (42 %)  1 (50 %)
Main duct dilation

  • 5 – 9 mm

  6 (78 %)  1 (100 %)

  •  ≥ 10 mm

  1 (22 %)  0 1
Follow-up, mean (range) 28.2 (6 – 66) 21 (16 – 26)  – 

MD-IPMN, main duct/mixed type intraductal papillary mucinous neoplasm; BD-IPMN, branched duct intraductal papillary mucinous neoplasm.

1

Including complete and partial responders.

2

Fischer exact test.